Buy or sell Estimize stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Estimize Stock
Financial estimates using aggregation from independent analysts
About Estimize Stock
Estimize is an open financial estimates platform which facilitates the aggregation of fundamental estimates from independent, buy-side, and sell-side analysts, along with those of private investors and students. Estimize has over 5149 analysts’ contributors, resulting in coverage on over 900 stocks each quarter. The firm was founded in 2011 by former quantitative hedge fund analyst Leigh Drogen, with the belief that the financial ecosystem was ready for an estimates platform built with an open and transparent philosophy. The Estimize consensus estimate is regularly referenced in notable financial media sources such as Forbes, Barron’s, The Wall Street Journal, CNN Money, The Street, Investor’s Business Daily and Business Week, amongst others. Estimize data is now available on major financial research platforms such as Bloomberg.
Funding History
| May 2011 | $200K |
|---|---|
| September 2012 | $1.2M |
| March 2014 | $1.2M |
| April 2015 | $6.0M |
| July 2015 | $3.6M |
Management
Co-Founder and CEO
Leigh Drogen
Chief Technology Officer
Brian Smith
Head of Product and Analytics
Josh Dulberger
Press
- Mar, 10 2016
- Feb, 10 2016
- Dec, 7 2015
- Nov, 1 2015
- Oct, 27 2015
- Oct, 26 2015
- Apr, 12 2015
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
